Peritoneal cytology in endometrial cancer

Neoplasma

Volumn 52, Issue 2, 2005, Pages 103-108

  Mlyncek, M ^a   Uharcek, P ^a  

^a Faculty Hospital Nitra   (Slovakia)

Author keywords

Endometrial carcinoma; Peritoneal cytology; Prognosis; Risk factors

Indexed keywords

CHROMIUM PHOSPHATE; PROGESTERONE;

ASCITES FLUID CYTOLOGY; CANCER CELL; CANCER RECURRENCE; CANCER SURVIVAL; DIAGNOSTIC VALUE; DRUG EFFICACY; ENDOMETRIUM CANCER; HISTOPATHOLOGY; HUMAN; INCIDENCE; OVARY CANCER; PROGNOSIS; RISK FACTOR; SHORT SURVEY; SYSTEMIC THERAPY;

EID: 17044413211     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (48)

1. ALCAZAR JL, ERRASTI T, ZORNOZA A. Saline infusion sonohysterography in endometrial cancer: assessment of malignant cells dissemination risk. Acta Obstet Gynecol Scand 2000; 79: 321-322.
2. BENEVOLO M, MARIANI L, VOCATURO G, VASSELLI S, NATALI PG, MOTTOLESE M. Independent prognostic value of peritoneal immunocytodiagnosis in endometrial carcinoma. Amer J Surg Pathol 2000; 24: 241-247.
3. CREASMAN WT, DISAIA PJ, BLESSING J, WILKINSON RH JR, JOHNSTON W, WEED JC JR. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol 1981; 141: 921-929.
4. CREASMAN WT, MORROW CP, BUNDY BN, HOMESLEY HD, GRAHAM JE, HELLER PB. Surgical pathologic spread patterns of endometrial cancer (GOG study). Cancer 1987; 60: 2035-2041.
5. CREASMAN WT. New gynecologic cancer staging. Obstet Gynecol 1990; 75: 287-288.
6. EBINA Y, HAREYAMA H, SAKURAGH N, YAMAMOTO R, FURUYA M et al. Peritoneal cytology and its prognostic value in endometrial carcinoma. Int Surg 1997; 82: 244-248.
7. FIGO Cancer Committee, W. Berlin, Sept. 1985. Staging announcement. Gynecol Oncol 1986; 25: 383-385.
8. GRIMSHAW RN, TUPPER WC, FRASER RC, TOMPKINS MG, JEFFREY JF. Prognostic value of peritoneal cytology in endometrial cancer. Gynecol Oncol 1990; 36: 97-100.
9. GU M, SHI W, BARAKAT RR, THALER HT, SAIGO PE. Peritoneal washings in endometrial carcinoma. A study of 298 patients with histopathologic correlation. Acta Cytol 2000; 44: 783-789.
10. GU M, SHI W, HUANG J, BARAKAT RR, THALER HT, SAIGO PE. Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer 2000; 90: 143-147.
11. HAROUNY VR, SUTTON GP, CLARK S, GEISLER HE, STEHMAN FB, EHRLICH CE. The importance of peritoneal cytology in endometrial cancer. Obstet Gynecol 1988; 72: 394-398.
12. HEATH R, ROSENMAN J, VARIA M, WALTON L. Peritoneal fluid cytology in endometrial cancer: its significance and the role of chromic phosphate (32P) therapy. Int J Radiat Oncol Biol Phys 1988; 15: 815-822.
13. HIRAI Y, FUJIMOTO I, YAMAUCHI K, HASUMI K, MASABUCHI K, SANO Y. Peritoneal fluid cytology and prognosis in patients with endometrial carcinoma. Obstet Gynecol 1989; 73: 335-338.
14. HIRAI Y, TAKESHIMA N, KATO T, HASUMI K. Malignant potential of positive peritoneal cytology in endometrial cancer. Obstet Gynecol 2001; 97: 725-728.
15. IDE P. Prognostic value of peritoneal fluid cytology in patients with endometrial cancer stage I. Eur J Obstet Gynecol Reprod Biol 1984; 18: 343-349.
16. ITO K, INOUE Y, OBATA K, NODA K. Peritoneal cytology in endometrial carcinoma. Tohoku J Exp Med 1992; 166: 387-394.
17. KADAR N, HOMESLEY HD, MALFETANO JH. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol 1992; 46: 145-149.
18. KASAMATSU T, ONDA T, KATSUMATA N, SAWADA M, YAMADA T et al. Prognostic significance of positive peritoneal cytology in endometrial cancer confined to the uterus. Brit J Cancer 2003; 88: 245-250.
19. KASHIMURA M, SUGIHARA K, TOKI N, MATSUURA Y, KAWAGOE T et al. The significance of peritoneal cytology in uterine cervix and endometrial cancer. Gynecol Oncol 1997; 67: 285-290.
20. KATO T, HIRAI Y, HASUMI K. Post-operative peritoneal washing cytology in cases of stage IIIa endometrial carcinoma with positive peritoneal cytology. Nippon Sanka Fujinka Gakkai Zasshi 1995; 47: 643-646.
21. KEETEL WG, ELKINS HB. Experience with radioactive colloidal gold in the treatment of ovarian carcinoma. Am J Obstet Gynecol 1956; 71: 553-568.
22. KENNEDY AW, WEBSTER KD, NUNEZ C, BAUER LJ. Pelvic washings for cytologic analysis in endometrial adenocarcinoma. J Reprod Med 1993; 38: 637-642.
23. KONSKI A, POULTER G, KEYS H, RUBIN P, BEECHAM J, DOANE K. Absence of prognostic significance, peritoneal dissemination and treatment advantage in endometrial cancer patients with positive peritoneal cytology. Int J Radiat Oncol Biol Phys 1988; 14: 49-55.
24. KUZEL D, TOTH D, KOBILKOVA J, DOHNALOVA A. Peritoneal washing cytology on fluid hysteroscopy and after curettage in women with endometrial carcinoma. Acta Cytol 2001; 45: 931-935.
25. LABASTIDA R, DEXEUS S, FABREGAS R, TRESSERRA F, FERNANDEZ A. Endometrial cancer: factors affecting survival. Eur J Gynaecol Oncol 2003; 24: 381-383.
26. LEVEQUE J, GOYAT F, DUGAST J, LOEILLET L, GRALL JY, LE BARS S. Value of peritoneal cytology after hysteroscopy in surgical stage I adenocarcinoma of the endometrium. Oncol Rep 1998; 5: 713-715.
27. LUO ML, SAKURAGI N, SHIMIZU M, SEINO K, OKAMOTO K et al. Prognostic significance of combined conventional and immunocytochemical cytology for peritoneal washings in endometrial carcinoma. Cancer 2001; 93: 115-123.
28. LURAIN JR. The significance of positive peritoneal cytology in endometrial cancer. Gynecol Oncol 1992; 46: 143-144.
29. MARIANI A, WEBB MJ, KEENEY GL, ALETTI G, PODRATZ KC. Endometrial cancer: predictors of peritoneal failure. Gynecol Oncol 2003; 89: 236-242.
30. MARIANI A, SEBO TJ, WEBB MJ, RIEHLE D, KATZMANN JA et al. Molecular and histopathologic predictors of distant failure in endometrial cancer. Cancer Detect Prev 2003; 27: 434-441.
31. McLELLAN R, DILLON MB, CURRIE JL, ROSENHEIM NB. Peritoneal cytology in endometrial cancer: a review. Obstet Gynecol Surv 1989; 44: 711-719.
32. OBERMAIR A, GERAMOU M, GUCER F, DENISON U, GRAF AH et al. Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C. Cancer 2000; 88: 139-143.
33. OBERMAIR A, GERAMOU M, TRIPCONY L, NICKLIN JL, PERRIN L, CRANDON AJ. Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus. Cancer Lett 2001; 164: 105-110.
34. PIVER MS, RECIO FO, BAKER TR, HEMPLING RE. A prospective trial of progesteron therapy for malignant peritoneal cytology in patients with endometrial carcinoma. Gynecol Oncol 1992; 47: 373-376.
35. SAGAWA T, YAMADA H, SAKURAGI N, FUJIMOTO S. A comparison between the preoperative and operative findings of peritoneal cytology in patients with endometrial cancer. Asia Oceania J Obstet Gynaecol 1994; 20: 39-47.
36. SANTALA M, TALVENSAARI-MATTILA A, KAUPPILA A. Peritoneal cytology and preoperative serum CA125 level are important prognostic indicators of overall survival in advanced endometrial cancer. Anticancer Research 2003; 23: 3097-3104.
37. SELVAGGI L, CORMIO G, CECI O, LOVERRO G, CAZZOLLA A, BETTOCCHI S. Hysteroscopy does not increase the risk of microscopic extrauterine spread in endometrial carcinoma. Int J Gynecol Cancer 2003; 13: 223-227.
38. SONODA Y, ZERBE M, SMITH A, LIN O, BARAKAT RR, HOSKINS WJ. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol Oncol 2001; 80: 378-382.
39. SUTTON GP. Peritoneal cytology in endometrial carcinoma. Cancer Treat Res 1989; 49: 41-52.
40. SUTTON GP. Significance of positive peritoneal cytology in endometrial cancer. Oncology (Huntingt) 1990; 4: 21-26.
41. TAKESHIMA N, NISHIDA H, TABATA T, HIRAI Y, HASUMI K. Positive peritoneal cytology in endometrial cancer: Enhancement of other prognostic indicators. Gynecol Oncol 2001; 82: 470-473.
42. TEBEU PM, POPOWSKI GY, VERKOOIJEN HM, CASALS J, LUDICKE F et al. Impact of peritoneal cytology on survival of endometrial cancer patients treated with surgery and radiotherapy. Brit J Cancer 2003; 89: 2023-2026.
43. TURNER DA, GERSHENSON DM, ATKINSON N, SNEIGE N, WHARTON AT. The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol 1989; 74: 775-780.
44. VECEK N, MARINOVIC T, IVIC J, JUKIC S, NOLA M et al. Prognostic impact of peritoneal cytology in patients with endometrial carcinoma. Eur J Gynaecol Oncol 1993; 14: 380-385.
45. WILLET GD. Prognostic value of cytologic peritoneal washings. Clin Lab Med 1985; 5: 265-274.
46. YANOH K, TAKESHIMA N, HIRAI Y, MINAMI A, TSUZUKU M et al. Morphologic analysis of positive peritoneal cytology in endometrial carcinoma. Acta Cytol 1999; 43: 814-819.
47. YANOH K, TAKESHIMA N, HIRAI Y, MINAMI A, TSUZUKU M et al. Identification of a high-risk subgroup in cytology-positive stage IIIA endometrial cancer. Acta Cytol 2001; 45: 691-696.
48. YAZIGI R, PIVER MS, BLUMENSON L. Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer. Obstet Gynecol 1983; 62: 359-362.